Date published: 2025-12-13

1-800-457-3801

SCBT Portrait Logo
Seach Input

HECTD1 Inhibitors

HECTD1, a HECT domain-containing E3 ubiquitin ligase, plays a critical role in regulating protein ubiquitination and degradation, as well as various cellular processes such as cell cycle progression, cell migration, and differentiation. As a member of the HECT (homologous to E6AP carboxyl terminus) domain family, HECTD1 possesses a conserved catalytic domain responsible for transferring ubiquitin molecules onto substrate proteins, thereby marking them for degradation by the proteasome or regulating their cellular localization and function. The substrate specificity of HECTD1 is mediated by its interaction with specific adaptor proteins or substrate receptors, which facilitate the recognition and ubiquitination of target proteins. Through its ubiquitin ligase activity, HECTD1 controls the turnover of key regulatory proteins involved in signaling pathways and cellular processes, thereby exerting tight regulation over various aspects of cell physiology.

Strategies for inhibiting HECTD1 could involve disrupting its interaction with substrate proteins or adaptor molecules, thereby preventing the ubiquitination and subsequent degradation of target proteins. Additionally, targeting the catalytic domain of HECTD1 with small molecule inhibitors or peptides may interfere with its ability to transfer ubiquitin molecules onto substrate proteins, thereby inhibiting its ubiquitin ligase activity. Furthermore, modulating the expression levels or stability of HECTD1 through strategies such as RNA interference or protein degradation pathways may provide alternative approaches for inhibiting HECTD1-mediated ubiquitination and downstream signaling. Elucidating the precise mechanisms underlying HECTD1 inhibition will provide valuable insights into its physiological roles and implications in cellular homeostasis and disease pathogenesis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

A proteasome inhibitor that can lead to an accumulation of ubiquitinated proteins, potentially causing feedback inhibition of HECTD1 activity.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

Another proteasome inhibitor, increases ubiquitinated protein levels, possibly leading to a reduction in HECTD1 activity due to feedback mechanisms.

MLN 4924

905579-51-3sc-484814
1 mg
$280.00
1
(0)

Inhibits NEDD8-activating enzyme, potentially affecting HECTD1 activity by altering neddylation processes related to ubiquitin ligases.

Ubiquitin E1 Inhibitor, PYR-41

418805-02-4sc-358737
25 mg
$360.00
4
(1)

Inhibits ubiquitin activating enzyme E1, which could disrupt the ubiquitination process and indirectly affect HECTD1's function.

NMS-873

1418013-75-8sc-478803
5 mg
$300.00
(0)

A p97/VCP inhibitor, impacts protein degradation pathways and may indirectly inhibit HECTD1 through altered ubiquitin-dependent processes.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$165.00
$575.00
60
(2)

Proteasome inhibitor that could lead to the accumulation of ubiquitinated proteins, potentially providing negative feedback to HECTD1 activity.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$134.00
$215.00
$440.00
$496.00
19
(2)

A selective proteasome inhibitor, can cause an accumulation of ubiquitinated proteins, which might indirectly inhibit HECTD1.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$72.00
$145.00
$265.00
$489.00
$1399.00
$99.00
19
(3)

A protease inhibitor that may affect protein degradation pathways, indirectly influencing HECTD1 activity.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

By inhibiting lysosomal function, it can affect protein degradation pathways, potentially impacting HECTD1 indirectly.

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$96.00
$250.00
$750.00
$1428.00
280
(6)

Inhibits vacuolar-type H+-ATPase, affecting lysosomal acidification and possibly indirectly inhibiting HECTD1.